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for nonrenal natural death, including, but not restricted to,The natural history of renal disease in Australian Aborigines.
cardiovascular deaths. Most of the risk for premature deathPart 2. Albuminuria predicts natural death and renal failure.
can be assessed by a simple urine test, and interventions thatBackground. The purpose of this study was to describe the
prevent development and progression of albuminuria and lossrelationship of albuminuria and glomerular filtration rate (GFR)
of GFR should not only prevent renal insufficiency, but power-with natural death and renal failure in an Australian Aboriginal
fully reduce mortality from natural causes as well.community with high rates of renal disease.
Methods. Study subjects were 825 adults (18 years, mean
33.6 years) or 88% of adults in a remote community who partici-
pated in a health screening program offered between 1990 and Standardized mortality rates of adult Aborigines in1997. The urinary albumin:creatinine ratio (ACR; g/mol) was
the Northern Territory of Australia are three to fiveused as the renal disease marker. Participants were followed
times those of non-Aboriginal Australians. The differen-for 1.0 to 9.8 years (mean 5.8 years) until renal failure, death,
the start of systematic antihypertensive/renal-protective treat- tial is especially marked among young adults, with the
ment or June 30, 2000. death rate of 25 to 44 year olds increased approximately
Results. Sixty-five people reached a terminal end point of 15-fold. Cardiovascular diseases are the leading single
renal failure or natural death. Sixteen people developed termi-
“cause” of death, although most other common causesnal renal failure, all of whom had an ACR of 34 at baseline
are also represented in great excess. Renal disease isexam. There were 49 other natural deaths, which were also
strongly correlated with increasing ACR and decreasing GFR reaching epidemic proportions. Renal deaths are increased
over a wide range. This was observed in people without diabe- 15- to 30-fold, and the annual incidence of people starting
tes and in people with normal and elevated blood pressures. treatment for end-stage renal disease (ESRD) exceeds
It applied to deaths associated with cardiovascular disease and
1000 per million [1–3]. ESRD treatment poses a crisisto deaths without an assigned primary or underlying cardiovas-
for health care budgets, and excess mortality is contribut-cular or renal cause. With adjustment for age, the association
with death was more robust with ACR than GFR. When com- ing to family, community, and cultural breakdown.
pared with people with an ACR 3.4, the hazard ratio (HR; Between 1990 and 1998, we conducted a study of renal
95% CI) for nonrenal natural death of persons with an ACR disease and its associations in one high-risk Aboriginal
3.4 to 33 was 3.0 (1.1 to 8.4), with an ACR 34 to 99, it was 5.4
community. The crude incidence of ESRD in that com-(1.8 to 15.9), and with an ACR 100, it was 6.5 (2.0 to 21).
munity recently reached 2700 per million, and its age-Regression equations predicted that each tenfold increase in
the ACR was associated with a 3.7-fold increase in all-cause adjusted adult mortality rates in the mid-1990s were four
natural death: a 400-fold increase in renal deaths, a 4-fold times the Australian aggregate [3, 4]. In that study, we
increase in cardiovascular deaths, and a 2.2-fold increase in non- showed that pathologic albuminuria was pervasive; fac-
renal noncardiovascular deaths. Eighty-four percent of all-cause
tors correlated with increasing albuminuria included age,natural death was associated with pathologic albuminuria.
body mass index (BMI), blood pressure, glucose andConclusion. All renal failure develops out of a background
of persistent albuminuria in this population. More important, lipid levels, diabetes, heavy drinking, the presence of
albuminuria and, inversely, GFR are powerful markers of risk scabies, a history of poststreptococcal glomerulonephri-
tis, and inversely, birth weight. Glomerular filtration rate
was inversely correlated with increasing levels of patho-Key words: renal failure, mortality in Aboriginal cohort, urine test,
logic albuminuria [5–9].progressive renal disease, chronic renal insufficiency, blood pressure,
diabetes. We have now studied the natural history of renal dis-
ease in adults in this community. This article describesReceived for publication September 14, 2000
the predictive value of albuminuria and, inversely, ofand in revised form December 27, 2000
Accepted for publication January 30, 2001 GFR for natural death as well as for renal failure. Our
accompanying article describes the progression of albu- 2001 by the International Society of Nephrology
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Table 2. Albumin:creatinine ratio (ACR) and estimated glomerularTable 1. Characteristics of 825 participants at baseline exam
filtration rate (GFR) by category in participants at baseline exam
Range or N Mean (SD) or %
ACR GFR
Male/female 432/393 52.4/47.6
Age years 18.0–76.4 33.6 (12.7) g/mol % mL/min/1.73 m2 %
BMI kg/m2 13.6–43.5 23.2 (5.1)
3.4 50.6 100 42.7SBP mm Hg 70–220 122 (19)
3.4–33 28.0 80–99 37.3DBP mm Hg 38–175 74 (14)
34–99 13.3 60–79 12.2BP 140/90 mm Hg 144 17.5
100 8.1 60 6.8Diabetes 86 10.4
Cholesterol 5.5 mmol/L 137 18.7
GGT 40 IU (739) 324 43.8
Hematuria dipstick 1 (815) 142 17.4
ACR g/mol (825)a 0.1–880 4.2 (3.6–4.8)
cords at the local clinics, Royal Darwin Hospital, andScrum creatinine lmol/L (794) 20–596 84.2 (30.9)
Estimated GFR dialysis unit and the official Northern Territory death
mL/min/1.73 m2 (794) 9.7–396 98.2 (27.3) registry.
Abbreviations are: BMI, body mass index; SBP, systolic blood pressure; DBP, Deaths were divided into natural deaths and deaths
diastolic blood pressure; BP, blood pressure; GGT, gamma glutamyl transferase;
of other causes (acute intoxications, accidents, drowning,ACR, albumin:creatinine ratio; GFR, glomerular filtration rate.
a ACR, geometric mean (95% CI) suicide, homicide, etc.). People experiencing these end
points were censored from the cohort when they died.
Natural end points were divided into the following cate-
gories, derived from the above data sources, by one ob-
minuria and glomerular filtration rate over time (this
server (W.H.): renal death, nonrenal death, cardiovascular
issue) [10].
death (primary or underlying), nonrenal, noncardiovas-
cular death), and all-cause natural death (which included
renal deaths). Certain causes of death were mutually ex-METHODS
clusive (renal vs. nonrenal causes; cardiovascular and/orThe study cohort consisted of all people who partici-
renal vs. deaths without these assignments). Some causespated in a community-wide renal disease screening pro-
of death overlapped; everyone with terminal renal fail-gram conducted between 1990 and April 30, 1997, who
ure, dialyzed or not, were designated as “renal deaths,”were 18 years of age at their first examination. Their
and everyone dying with a primary or underlying cardio-course was followed until they reached a terminal end
vascular cause, including those with renal failure, werepoint, or until they started systematic antihypertensive/
given a cardiovascular assignment. However, no individ-renal protective treatment, or through June 30, 2000.
ual was counted twice in any particular end point cate-Their first examination included measurement of height,
gory. Correlations of these end points with ACR andweight, blood pressure, and urinary albumin:creatinine
GFR category at baseline exam were evaluated.ratio (ACR; g/mol) on a random urine specimen using
the Beckman radioimmunoassay for albumin concentra- Statistics
tion. ACR was categorized as follows: ACR 3.4, not
Statistical analyses were performed using Stata soft-clearly elevated; ACR  3.4 to 33, microalbuminuria;
ware [14]. Rates of terminal events were expressed perACR 34 to 99, moderate overt albuminuria; and ACR
100 person-years of follow-up. The Kaplan–Meier method100, heavy overt albuminuria. Serum creatinine levels
was used to estimate the cumulative incidence of end
were also measured in most (N  794), and glomerular
points. Cox proportional hazards models were used to
filtration rate (GFR) was estimated by the Cockcroft– evaluate relationships between ACR and categories and
Gault formula [11]. People with a past history of diabetes end points, adjusting for potential confounding factors.
or who met World Health Organization guidelines after a Hazard ratios (HRs) were estimated using people in the
75 g oral glucose challenge were designated as “diabetic” lowest ACR and highest GFR categories as the referent
[12]. Levels of serum cholesterol and serum gamma glu- group. The adjusted population attributable fraction
tamyl transferase (GGT) [13] were measured in most (PAF) of end points associated with albuminuria was
people. calculated by Poisson regression, adjusted for sex, age,
Eight hundred twenty-five people qualified for the and time [15, 16].
study. They constituted 98% of all adults screened in
the program, with only 16 exclusions from the entire
RESULTSgroup due to incomplete clinical data, and they repre-
sented 88% of the estimated adult population. People The clinical characteristics of participants at baseline
were censored from the cohort if/when they started on exam are shown in Tables 1 and 2. Males and females
systematic treatment. Their fate was recorded, with were equally represented. Their ages ranged from 18 to
76 years, with a youthful mean of 33.6 years. They had100% ascertainment, through community networks, re-
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Table 3. Categories of terminal end points
Events Definition Comments
All-cause natural 65 All natural deaths, including renal deaths (see below) End point date is that of death or start of
deaths dialysis
Renal deaths 16 People starting dialysis (12) and people dying with chronic renal End point date is that of death without
failure without dialysis (4) dialysis or start of dialysis
Nonrenal deaths 49 All deaths excluding renal deaths End point is date of death
Cardiovascular 27 Death with cardiovascular disease, (heart failure, heart attack, End point is date of death; includes people
deaths cardiac arrest and stroke) as primary or underlying cause on dialysis or with chronic renal failure
who died a cardiovascular death
Noncardiovascular, 28 Excludes cardiovascular and renal deaths; deaths were End point is date of death
nonrenal deaths pneumonia/chronic lung disease (12), cancer (9), liver disease
(3), sepsis (2), amyloidosis (1), and theophylline toxicity (1)
modest average BMIs and blood pressures by Caucasian in the first three categories. Survival is worst for people
with a GFR in the lowest category, with only 27.3 andstandards. Diabetes was diagnosed in 10.4%. Half had
pathologic albuminuria, and 6.8% had a GFR 60 mL/ 43.9% avoiding all-case death and nonrenal death, re-
spectively, at eight years; there is some discriminationmin/1.73 m2. These are essentially the characteristics of
the entire group who participated in the screening [5]. in survival among the higher categories, but it not as
marked as among the lower categories of ACR.Participants were followed for a total of 4778 patient-
years, with an individual range of 1 to 9.8 years and a The trends in nonrenal natural deaths were confirmed
in clinical “subgroups” of participants as well, as shownmean of 5.79 years. Seventy-five people reached an end
point. Ten died from violence, suicide, accident, or intox- in Table 5. Rates of natural death rose with increasing
ACR and decreasing GFR in people without diabetesications. Sixty-five people (7.9%) reached a natural end
point, as shown in Table 3. Sixteen people (24.6%) devel- and in people with “normal” as well as “elevated” blood
pressures at baseline. Diabetics had a continuous grada-oped terminal renal failure; four of these died without
dialysis, and 12 went onto dialysis, with 4 dying later and tion of nonrenal death rates with decreasing GFR, but
death rates were moderately elevated through all catego-8 surviving to the end of the study period. Twenty-seven
deaths, or 42% of the total, had a direct or underlying ries of ACR. The strength of the observations in diabet-
ics, however, was compromised by the small numbers ofcardiovascular cause, and 57% of the end points were
associated with cardiovascular events or chronic renal participants (N  85) and of nonrenal terminal events
(N  10).failure. Twenty-eight deaths, or 43% of end points, had
neither a cardiovascular nor renal assignment, with causes Table 6 shows the calculated hazard ratios (HRs) for
various categories of natural death by ACR and GFRdetailed in Table 3. These assignments potentially under-
state the contribution of coexisting cardiovascular dis- categories. The association of ACR 100 with renal
deaths is immensely powerful. Cardiovascular deathsease to death, which is especially likely in older people,
those dying with chronic lung disease and diabetics dying were associated with increasing ACR category, and the
trend persisted after adjusting for age, although signifi-with infection.
All renal deaths occurred in people with overt albu- cance was only retained for the highest category. The
association of nonrenal, noncardiovascular deaths withminuria at baseline, as shown in Table 4, and 88% had
a baseline ACR of 100 g/mol. The geometric mean increasing ACR category was also strong and persisted
with age adjustment. As a result of all of these associa-ACR of people developing renal failure was 240 g/mol.
Although renal failure was powerfully segregated among tions, the correlations of ACR category with all-cause
natural death were very strong. Cardiovascular deathspeople with GFRs 60 at baseline, there were cases of
renal death in persons in every category of baseline GFR. and nonrenal, noncardiovascular deaths also increased
with decreasing GFR, but none retained significanceTable 4 also shows that rates of nonrenal natural death
increased over all categories of increasing ACR and de- after adjustment for age.
Table 7 summarizes all measured factors that werecreasing GFR. Figures 1 and 2 show Kaplan–Meier sur-
vival curves for all-cause natural death (including renal significantly correlated with natural end points and the
effect of accounting for baseline ACR (gender, GGTdeath) and for natural, nonrenal deaths by baseline cate-
gories of ACR and GFR. Survival is clearly worst for levels, and microscopic hematuria were not significantly
correlated with outcomes and are not included). Renalpeople in the highest ACR category, with only 28.4%
avoiding all-cause deaths and 65% avoiding nonrenal deaths were associated with age, baseline ACR and
GFR. They were also significantly correlated with blooddeaths at eight years. However, there is significant dis-
crimination of survival among people with baseline ACR pressure, BMI, diabetes, and cholesterol levels, but these
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Table 4. Terminal events by baseline albumin:creatinine ratio (ACR) and glomerular filtration rate (GFR) categories
Renal deaths Nonrenal natural death All natural deaths
ACR category 16 events 49 events 65 events
3.4 Events/person-year 0/2697 5/2697 5/2697
Rate (95% CI)a 0 0.19 (0.08–0.45) 0.19 (0.08–0.44)
3.4–33 Events/person-year 0/1376 20/1376 20/1375
Rate (95% CI) 0 1.45 (0.94–2.25) 1.45 (0.94–2.25)
34–99 Events/person-year 2/481 15/481 17/481
Rate (95% CI) 0.42 (0.10–1.66) 3.12 (1.88–5.17) 3.53 (2.20–5.69)
100 Events/person-year 14/224 9/224 23/224
Rate (95% CI) 6.23 (3.70–10.54) 4.01 (2.09–7.72) 10.30 (6.82–15.44)
GFR Category 16 events 47 events 63 events
100 Events/person-year 2/2023 5/2027 7/2023
Rate (95% CI) 0.10 (0.02–0.40) 0.25 (0.10–0.59) 0.35 (0.16–7.26)
80–99 Events/person-year 1/1796 15/1796 16/1795
Rate (95% CI) 0.06 (0.01–0.40) 0.84 (0.50–1.39) 0.89 (0.55–1.45)
60–79 Events/person-year 2/599 9/599 11/599
Rate (95% CI) 0.33 (0.08–1.33) 1.50 (0.78–2.89) 1.83(1.02–3.31)
60 Events/person-year 11/210 18/210 29/210
Rate (95% CI) 5.24 (2.90–9.47) 8.58 (5.41–13.62) 13.82 (9.61–19.89)
a Rate per 100 person-years (95% CI)
Fig. 1. Survival by baseline urinary albumin:
creatinine ratio (ACR) in (A) all-cause natu-
ral death and (B) nonrenal death.
Fig. 2. Survival by baseline glomerular filtra-
tion rate (GFR) in (A) all-cause natural death
and (B) nonrenal death.
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Table 5. Nonrenal death by diabetes and blood pressure (BP) status
People with BP People with BP
Nondiabetics Diabetics 140/90 140/90
ACR category 39 events 10 events 33 events 16 events
3.4 Events/person-year 3/2634 2/62 3/2484 2/214
Rate (95% CI)a 0.11 (0.04–0.35) 3.20 (0.80–12.8) 0.12 (0.04–0.37) 0.94 (0.23–3.74)
3.4–33 Events/person-year 18/1256 2/120 15/1111 5/265
Rate (95% CI) 1.43 (0.90–2.27) 1.67 (0.42–6.66) 1.35 (0.81–2.24) 1.89 (0.79–4.53)
34–99 Events/person-year 12/395 3/86 11/333 4/148
Rate (95% CI) 3.04 (1.73–5.35) 3.49 (1.12–10.80) 3.30 (1.83–5.96) 2.71 (1.02–7.21)
100 Events/person-year 6/141 3/84 4/95 5/129
Rate (95% CI) 4.27 (1.92–9.50) 3.59 (1.16–11.13) 4.21 (1.58–11.22) 3.87 (1.61–9.30)
GFR Category 37 events 10 events 31 events 16 events
100 Events/person-year 4/1855 1/172 4/1740 1/287
Rate (95% CI) 0.21(0.08–0.57) 0.58 (0.08–4.12) 0.23 (0.09–0.61) 0.35 (0.05–2.48)
80–99 Events/person-year 13/1692 2/104 12/1551 3/245
Rate (95% CI) 0.77 (0.45–1.32) 1.93 (0.48–7.71) 0.78 (0.44–13.62) 1.22 (0.40–3.80)
60–79 Events/person-year 8/571 1/28 7/480 2/120
Rate (95% CI) 1.40 (0.70–2.80) 3.56 (0.05–25.24) 1.46 (0.70–3.06) 1.68 (0.42–6.69)
60 Events/person-year 12/169 6/42 8/121 10/89
Rate (95% CI) 7.14 (4.05–12.57) 14.38 (6.55–32.00) 6.59 (3.30–13.18) 11.30 (6.08–21.01)
Abbreviations are: ACR, albumin:creatinine ratio; GFR, glomerular filtration rate.
a Rate per 100 person-years (95% CI)
Table 6. Hazard ratios (95% CI) for various categories of natural death by albumin:creatinine ratio (ACR)
and glomerular filtration rate (GFR) categories, unadjusted and adjusted for age and sexa
Cardiovascular Noncardiovascular, All natural
Renal deaths death nonrenal death deaths
ACR category 16 events 27 events 28 events 65 events
3.4 — 1 1 1
3.4–33 — 5.9 (1.6–21.9) 10.8 (2.4–48.7) 7.9 (3.0–21.0)
2.2 (0.6–8.8) 4.5 (0.95–21.7) 3.8 (1.4–10.5)
34–99 — 11.9 (3.0–47.8) 28.5 (6.2–130) 20.3 (7.5–55.3)
3.6 (0.8–15.9) 9.9 (2.0–48.7) 8.2 (2.9–23.4)
100 — 40.6 (10.9–152) 24.8 (4.8–128) 61.6 (23.2–163)
11.0 (2.7–45.7) 8.3 (1.5–46) 23.1 (8.3–64.8)
GFR Category 16 events 26 events 27 events 63 events
100 1 1 1 1
80–99 0.6 (0.05–6.1) 3.9 (0.8–18.7) 3.4 (0.9–12.7) 2.6 (1.05–6.2)
0.6 (0.05–6.2) 2.8 (0.6–13.7) 2.1 (0.6–7.9) 2.1 (0.8–5.1)
60–79 3.4 (0.5–24.0) 8.2 (1.6–42.2) 5.8 (1.4–24.1) 5.3 (2.1–13.7)
4.4 (0.6–32.7) 2.9 (0.5–17.2) 1.5 (0.3–7.4) 2.8 (1.0–7.9)
60 57.5 (12.7–261) 55.8 (12.3–253) 30.6 (8.5–109.8) 43.1 (18.8–98.8)
149 (26.4–844) 7.0 (0.99–49.3) 3.1 (0.6–16.4) 11.7 (3.8–35.9)
a In all calculations the effect of age is highly significant (P  0.001) and the effect of sex is not significant
associations lost significance after accounting for base- in the model with P values 0.1. Only ACR and GFR
were significant predictors of renal failure. Age, ACR,line ACR. Cardiovascular deaths were significantly cor-
related with age, ACR, GFR, DBP, and cholesterol lev- elevated cholesterol, and BMI (inversely) were signifi-
cant predictors of cardiovascular death, with an esti-els, but with adjustment for ACR, correlations with GFR
and DBP lost significance, while BMI, inversely, acquired mated fourfold increase in risk for every tenfold increase
in ACR. Only age and ACR predicted nonrenal, noncar-significance. Nonrenal, noncardiovascular deaths were
correlated only with age and baseline ACR. The combined diovascular death, with a 2.2-fold increase estimated for
every tenfold increase in ACR. Finally, age, ACR, GFR,end point of all-cause natural death was significantly
correlated with age, ACR and GFR. It was also corre- and diabetes (marginally) predicted all-cause natural
death, with estimates of 3.7-fold increase for every ten-lated with BP, diabetes, and cholesterol levels, but the
associations were no longer significant after adjustment fold increase in ACR.
Table 9 summarizes the fraction of end points pre-for ACR, although, again, BMI acquired significance.
The final best models of various categories of end dicted by the presence of pathologic albuminuria at base-
line. Accounting for time of follow-up, age, and sex, 100%points are summarized in Table 8, with variables retained
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Table 7. Factors with significant correlations with end points by category, hazard ratios (CI), adjusted for age,
and adjusted for age and baseline ACR
Nonrenal,
Renal death Cardiovascular noncardiovascular All natural death
Age years 1.06 (1.03–1.09), P 0.001 1.10 (1.07–1.12), P 0.001 1.09 (1.07–1.12), P 0.001 1.09 (1.07–1.10), P 0.001
Log10 ACR 105 (26.0–421), P 0.001 3.44 (1.81–6.53), P 0.001 2.23 (1.21–4.11), P 0.010 4.28 (2.89–6.44), P 0.001
GFR mL/min 0.91 (0.89–0.93), P 0.001 0.97 (0.95–0.99), P 0.014 1.00 (0.97–1.01), P 0.492 0.96 (0.95–0.98), P 0.001
0.94 (0.91–0.97), P 0.001 0.98 (0.96–1.00), P 0.097 1.00 (0.98–1.02), P 0.734 0.98 (0.97–0.99), P 0.001
SBP mm Hg 1.04 (1.02–1.06), P 0.001 1.01 (0.99–1.02), P 0.40 1.00 (0.98–1.02), P 0.71 1.01 (1.00–1.03), P 0.32
1.00 (0.98–1.02), P 0.882 1.00 (0.98–1.02), P 0.806 1.00 (0.98–1.01), P 0.74 1.00 (0.99–1.01), P 0.977
DBP mm Hg 1.02 (1.03–1.08), P 0.001 1.03 (1.01–1.06), P 0.008 1.02 (0.99–1.04), P 0.218 1.04 (1.02–1.05), P 0.001
1.01 (0.97–1.05), P 0.598 1.02 (0.99–1.05), P 0.220 1.00 (0.98–1.03), P 0.795 1.01 (0.99–1.03), P 0.187
SBP 140 or 5.93 (2.01–17.5), P 0.001 1.69 (0.77–3.72), P 0.192 0.73 (0.31–1.76), P 0.49 1.56 (0.93–2.62), P 0.092
DBP 90 0.93 (0.31–2.90), P 0.895 1.11 (0.49–2.50), P 0.806 0.54 (0.22–1.33), P 0.181 0.92 (0.54–1.56), P 0.758
BMI kg/m2 1.11 (1.02–1.21), P 0.016 0.95 (0.86–1.04), P 0.280 0.96 (0.88–1.05), P 0.424 0.99 (0.94–1.05), P 0.715
0.95 (0.84–1.07), P 0.414 0.88 (0.79–0.98), P 0.018 0.93 (0.84–1.03), P 0.143 0.92 (0.86–0.98), P 0.012
Diabetes 6.23 (2.19–17.7), P 0.001 2.16 (0.89–5.20), P 0.088 0.97 (0.33–2.84), P  0.96 2.22 (1.27–3.91), P 0.006
0.66 (0.18–2.38), P 0.529 1.61 (0.65–4.00), P 0.301 0.78 (0.26–2.27), P 0.630 1.44 (0.80–2.58), P 0.221
Cholesterol 3.39 (1.27–9.09), P 0.016 3.37 (1.53–7.44), P 0.003 0.71 (0.24–2.04), P  0.96 1.82 (1.07–3.13), P 0.028
5.5 mmol/L 1.28 (0.45–3.63), P 0.644 2.30 (1.01–5.27), P 0.049 0.51 (0.17–1.51), P 0.226 1.08 (0.62–1.89), P 0.278
Abbreviations are: ACR, albumin:creatinine ratio; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Table 9. Terminal events associated withTable 8. Multivariate models of end points, hazard ratios (95% CI)
albumin:creatinine ratio (ACR) 3.4
Renal deaths
Log10 ACR 484 (48–3914), P0.001 Proportion
Category of death Events/total of events PAF (95% CI)GFR mL/min 0.95 (0.92–0.97), P0.001
Cardiovascular deaths
Renal 16/16 1.00 1.00Age years 1.07 (1.04–1.10), P0.001
Nonrenal 44/49 0.90 0.75 (0.39–0.89)Log10 ACR 3.99 (1.88–8.46), P0.001 Cardiovascular 24/27 0.89 0.65 (0.13–0.89)Cholesterol 5.5 mmol/L 2.49 (1.08–5.75), P0.032
Noncardiovascular,BMI kg/m 0.87 (0.78–0.97), P0.016
nonrenal 26/28 0.93 0.80 (0.21–0.95)Nonrenal, noncardiovascular deaths
All-cause naturalAge years 1.08 (1.06–1.11), P0.001
deaths 60/65 0.92 0.84 (0.57–0.93)Log10 ACR 2.22 (1.21–4.11), P0.010
All-cause natural deaths PAF is population-attributable fraction, adjusted for age, sex and time of
follow-up.Age years 1.03 (1.01–1.08), P0.007
Log10 ACR 3.72 (2.39–5.79), P0.001
GFR mL/min 0.98 (0.97–0.99), P0.001
Diabetes 1.70 (0.93–3.11), P0.084
Abbreviations are: GFR, glomerular filtration rate; BMI, body mass index. Rates of nonrenal natural death were correlated over a
continuum with levels of ACR. This association persisted
after accounting for age. ACR was a powerful determi-
nant of cardiovascular deaths, although age, high choles-of cases of renal failure, 75% of nonrenal deaths, 65%
terol levels, and BMI (inversely) were also independentof cardiovascular deaths, 80% of nonrenal, noncardio-
predictors. The inverse association of mortality withvascular deaths, and 84% of all-cause natural deaths were
BMI, which contrasts with the facilitating effect of higherpredicted by a level of ACR 3.4 at first examination.
BMIs on progression of renal disease [10], has been
described previously (abstract; Wang et al, Australasian
DISCUSSION Epidemiologist 6:17, 1999). While we propose that it
represents effects of malnutrition, lower socioeconomicIn this community, albuminuria and, inversely, GFR,
predict renal failure over the short and intermediate status, and low birth weight on mortality, the phenome-
non needs further study. ACR on a continuum was alsoterm. This is compatible with findings in other studies
[17–21]. Renal failure developed only in people with strongly correlated with nonrenal and noncardiovascular
deaths and, along with age, was the only significant pre-overt albuminuria at baseline and was largely, although
not entirely, segregated among people with previous seri- dictor of risk for that outcome. GFR (inversely) was asso-
ciated with cardiovascular deaths, although the effectously compromised GFRs. Age, diabetes, blood pres-
sure, and BMI were also significant predictors of renal was mostly mediated through age. It had no predictive
value for nonrenal, noncardiovascular deaths.failure, but their effects were largely represented or me-
diated through high ACRs and low GFRs, because in In the last few years, there has been increasing focus
on renal disease in Aboriginal people, prompted by themultivariate models only these two measures were sig-
nificant independent predictors of risk. costs of treatment for people with ESRD [2, 3]. However,
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the association of renal markers with premature death risk populations and its predictive value for mortality be
is far more significant in clinical and human terms. In further evaluated. It follows too, that interventions that
this study, 84% of all-cause natural deaths and 83% of reduce development and progression of albuminuria
natural deaths without an assigned renal or cardiovascu- (public health and primary care initiatives, as well as
lar cause were predicted by levels of albuminuria at or medical treatment) should reduce mortality. The results
above the microalbuminuria threshold. This accounts for of a treatment program in this community centered
all, or almost all, of the excess risk for mortality in this around the use of angiotensin-converting enzyme inhibi-
population. It appears that renal failure develops only tion and good blood pressure control support this con-
in the people with albuminuria who escape the attendant tention: Progression of ACR and deterioration of GFR
risk of premature death long enough to allow nephropa- have been arrested on a group basis, and natural deaths,
thy to run its full course. as well as renal failure, have fallen by 50% within three
The predictive value of albuminuria for nonrenal death years [39]. We propose that remarkable reductions in
has been described in other reports, in a wide range of age-specific and age-standardized rates of deaths and
ethnic groups [22–34]. It has been more readily exposed renal failure rate will be achieved in other communities
among the higher death rates of people with diabetes by treating people with “isolated” pathologic albumin-
[22–27], hypertension [28, 29], high cardiovascular risk uria as well as those with hypertension and diabetes,
[27, 28], and the older population [30], although it has resulting in an increase in overall life expectancy and
also been reported in people without diabetes, with nor- dialysis-free life expectancy.
mal blood pressure, and in the general population [28,
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